Zenith Healthcare Limited (BOM:530665)
3.350
-0.010 (-0.30%)
At close: Feb 12, 2026
Zenith Healthcare Revenue
Zenith Healthcare had revenue of 22.67M INR in the quarter ending September 30, 2025, a decrease of -25.15%. This brings the company's revenue in the last twelve months to 112.08M, down -11.89% year-over-year. In the fiscal year ending March 31, 2025, Zenith Healthcare had annual revenue of 113.89M, down -21.78%.
Revenue (ttm)
112.08M
Revenue Growth
-11.89%
P/S Ratio
1.62
Revenue / Employee
2.49M
Employees
45
Market Cap
181.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 113.89M | -31.71M | -21.78% |
| Mar 31, 2024 | 145.61M | 13.36M | 10.10% |
| Mar 31, 2023 | 132.25M | -93.34M | -41.38% |
| Mar 31, 2022 | 225.58M | 87.00M | 62.78% |
| Mar 31, 2021 | 138.58M | 17.91M | 14.84% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Add-Shop E-Retail | 1.46B |
| Sunrest Lifescience | 520.34M |
| Cian Healthcare | 232.80M |
| Beryl Drugs | 176.65M |
| Norris Medicines | 72.84M |
| Hamps Bio | 71.20M |
| Desh Rakshak Aushdhalaya | 62.53M |
| Colinz Laboratories | 58.40M |